Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus

Figure 1

Changes in the fasting blood glucose levels (a) and glucose levels 2 h after HMS5552 administration (b) in the rats of the different groups. HMS-L group, low-dose (10 mg/kg) HMS5552-treated diabetic group; HMS-H group, high-dose (30 mg/kg) HMS5552-treated diabetic group. The data are expressed as the mean ± SD ().

(a)

(b)